Advertisement
News
Advertisement

Valeant Pharma authorizes $500M securities buyback

Tue, 03/30/2010 - 7:17am
The Associated Press

Valeant Pharmaceuticals International said Tuesday its board authorized a $500 million repurchase of stock, convertible debt or senior notes.

Valeant said it had bought back $415 million in securities under previous authorizations, and can still buy another $85 million under that plan. The authorization lasts until March 2013.

In morning trading, Valeant shares rose 27 cents to $42.38. The stock has been trading at annual highs and peaked at a 52-week high of $42.65.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading